Peptide Degradation and Contamination Risk: BPC-157 sourced from unregulated research suppliers carries the risk of contamination, incorrect peptide sequencing, or degraded compound from improper storage, introducing unpredictable biological effects beyond the peptide's known pharmacology
Peptides support consistent habits, they do not replace them
Do you have to inject GHK-Cu peptide
In the D-Gal + FOXO4-DRI group, mice also received D-galactose injections and, after 4 weeks, were given intraperitoneal injections of FOXO4-DRI (5 mg/kg, MCE, HY-P4157) every 2 days for 4 weeks, followed by tissue collection
It is not a tissue-repair peptide like BPC-157, not a growth hormone secretagogue like CJC-1295, and not a mitochondrial agent like SS-31
Most episodes resolve within 3-5 days at a stable dose